RenovaCare Provides Update On Clinical Trial for the SkinGun™ and CellMist™ System for Wound Healing
“We’ve achieved some impressive technical results to-date. The next steps for us are to advance our breakthrough technology towards market through the regulatory and clinical studies process…”
Thomas Bold, President and CEO
